Literature DB >> 1618228

Of mice and men...

A C Perkins.   

Abstract

Entities:  

Mesh：

Year:  1992        PMID： 1618228     DOI： 10.1007/bf00177363

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN： 0340-6997


× No keyword cloud information.
  10 in total

1.  Continuous cultures of fused cells secreting antibody of predefined specificity.

Authors:  G Köhler; C Milstein
Journal:  Nature       Date:  1975-08-07       Impact factor: 49.962

2.  MAb 170H.82: an evaluation of a novel panadenocarcinoma monoclonal antibody labelled with 99Tcm and with 111In.

Authors:  A J McEwan; G D MacLean; H R Hooper; T Sykes; S A McQuarrie; L Golberg; D M Bodnar; S L Lloyd; A A Noujaim
Journal:  Nucl Med Commun       Date:  1992-01       Impact factor: 1.690

3.  The binding parameters of radiolabelled monoclonal F (ab')2 and Fab' fragments relative to immunoglobulin G in reactions with surface-bound antigens.

Authors:  J G Fjeld; T E Michaelsen; K Nustad
Journal:  Eur J Nucl Med       Date:  1992

4.  Evaluation of monoclonal idiotypic-specific antibodies as clearing antibodies for enhancement of target localisation by tumour-specific monoclonal antibodies: diversity of effects in nude mice with human tumour xenografts.

Authors:  M V Pimm; S J Gribben
Journal:  Eur J Nucl Med       Date:  1992

5.  Alterations in an indium-111 Fab' under conditions of utilization.

Authors:  S E Halpern; J P Tarburton; E Sudora; P Hagan
Journal:  Eur J Nucl Med       Date:  1992

6.  Lymphoma imaging with a new technetium-99m labelled antibody, LL2.

Authors:  S Murthy; R M Sharkey; D M Goldenberg; R E Lee; C M Pinsky; H J Hansen; K Burger; L C Swayne
Journal:  Eur J Nucl Med       Date:  1992

7.  Tumour localization and pharmacokinetics of iodine-125 human monoclonal IgM antibody (COU-1) and its monomeric and half-monomeric fragments analysed in nude mice grafted with human tumour.

Authors:  H Ditzel; J W Rasmussen; K Erb; J C Jensenius
Journal:  Eur J Nucl Med       Date:  1992

8.  Gamma imaging with negatively charge-modified monoclonal antibody: modification with synthetic polymers.

Authors:  B A Khaw; A Klibanov; S M O'Donnell; T Saito; N Nossiff; M A Slinkin; J B Newell; H W Strauss; V P Torchilin
Journal:  J Nucl Med       Date:  1991-09       Impact factor: 10.057

9.  In vivo tumor targeting of a recombinant single-chain antigen-binding protein.

Authors:  D Colcher; R Bird; M Roselli; K D Hardman; S Johnson; S Pope; S W Dodd; M W Pantoliano; D E Milenic; J Schlom
Journal:  J Natl Cancer Inst       Date:  1990-07-18       Impact factor: 13.506

10.  Operation manual for control of production, preclinical toxicology and phase I trials of anti-tumour antibodies and drug antibody conjugates. Prepared by a Joint Committee of the: Cancer Research Campaign National Institute for Biological Standards and Control.

Authors: 
Journal:  Br J Cancer       Date:  1986-09       Impact factor: 7.640
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.